alexion pharmaceuticals inc
Sven Ante Lundberg M.D.
Head of Translational Medicine and Vice President, Alexion Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Dr. Sven Ante Lundberg, Bill MD serves as Head of Translational Medicine and Vice President at Alexion Pharmaceuticals, Inc. Dr. Lundberg has a wealth of knowledge and experience in the fields of immunology and oncology. Dr. Lundberg served as Chief Medical Officer of Taligen Therapeutics, Inc. since April 2010. Dr. Lundberg has held senior clinical and medical affairs roles in both large pharmaceutical and emerging biopharmaceutical companies, including Genzyme, Wyeth, ...
352 Knotter DrivePhone: 203-272-2596
Cheshire, Connecticut 06410
Board Members Memberships*There is no Board Members Memberships data available.
Massachusetts Institute of Technology
Harvard Medical School
University of Massachusetts, Amherst
Stanford University School of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Jay T. Flatley||Chief Executive Officer and Director|
|Leonard S. Schleifer M.D., Ph.D.||Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee|
Regeneron Pharmaceuticals, Inc.
|Jeffrey M. Leiden M.D., Ph.D.||Chairman, Chief Executive Officer and President|
Vertex Pharmaceuticals Incorporated
|Rakesh Sachdev||Chief Executive Officer, President and Director|
|Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)||Co-Chairman, Managing Director, Chief Executive Officer, Member of The Management Council, Member of Management Committee, Member of Investment Committee, Member of Corporate Social Responsibility Committee and Member of Stakeholders' Relationship Committee|
Dr. Reddy's Laboratories Ltd.
|6.3M||Compensation as of Fiscal Year 2013.|